Eledon Pharmaceuticals, Inc. (ELDN)
3.025
+0.10
(+3.24%)
USD |
NASDAQ |
Sep 04, 12:20
Eledon Pharmaceuticals Net Income (Annual) : -45.62M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -45.62M |
| December 31, 2024 | -36.18M |
| December 31, 2023 | -116.54M |
| December 31, 2022 | -87.97M |
| December 31, 2021 | -34.51M |
| December 31, 2020 | -22.81M |
| December 31, 2019 | -16.01M |
| Date | Value |
|---|---|
| December 31, 2018 | -14.06M |
| December 31, 2017 | -10.78M |
| December 31, 2016 | -0.941M |
| December 31, 2015 | -45.09M |
| December 31, 2014 | -23.30M |
| December 31, 2013 | -15.72M |
| December 31, 2012 | -9.649M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.953B |
| Viking Therapeutics, Inc. | -359.64M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |